惠誉计划撤销诺华制药评级

DoNews
Aug 27

北京时间2025年8月27日,国际评级机构惠誉宣布计划撤销对瑞士制药公司诺华制药的信用评级。此举源于惠誉对当前市场环境及诺华财务结构的综合评估。此次评级撤销将影响投资者对诺华信用状况的判断,并可能对其融资成本产生一定影响。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10